Blueprint Medicines (BPMC) Misses Q1 EPS by 8c
Blueprint Medicines (NASDAQ: BPMC) reported Q1 EPS of ($0.84), $0.08 worse than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Blueprint Medicines (BPMC) click here.
Blueprint Medicines (NASDAQ: BPMC) reported Q1 EPS of ($0.84), $0.08 worse than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Blueprint Medicines (BPMC) click here.